Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells

Maryam Ghaffari; Gholamreza Dehghan; Behzad Baradaran; Amir Zarebkohan; Behzad Mansoori; Jafar Soleymani; Ali Ezzati; Michael R Hamblin

doi:10.1016/j.colsurfb.2019.110762

Related publications

Article2024

PAMAM dendrimers based co-delivery of methotrexate and berberine for targeting of Hela cancer cells

Hossein Majidzadeh, Mostafa Araj‐Khodaei, Ayuob Aghanejad, Maryam Ghaffari, Amir Jafari, Forough Jenanifard, Ali Ezzati, Hashem Andishmand, Michael R Hamblin

Article2022

Co-delivery of curcumin and Bcl-2 siRNA to enhance therapeutic effect against breast cancer cells using PEI-functionalized PLGA nanoparticles

Leila Mohammad Gholinia Sarpoli, Shohreh Zare Karizi, Erfan Heidari, Akbar Hasanzadeh, Mehrdad Bayandori, Fereshteh Azedi, Michael R Hamblin, Mahdi Karimi

Article2025

Targeted co-delivery nanosystem based on methotrexate, curcumin, and PAMAM dendrimer for improvement of the therapeutic efficacy in cervical cancer

Ayuob Aghanejad, Shiva Kheiriabad, Maryam Ghaffari, Simin Namvar Aghdash, Nazdar Ghafouri, Ali Ezzati, Hashem Andishmand, Michael R Hamblin

Corrigendum2025

Corrigendum to: “Co-delivery of methotrexate and berberine based on PAMAM dendrimers for targeting HeLa cancer cells” [Toxicol. Rep. Volume 13, December 2024, 101765]

Hossein Majidzadeh, Mostafa Araj‐Khodaei, Ayuob Aghanejad, Maryam Ghaffari, Amir Jafari, Forough Jenanifard, Ali Ezzati, Hashem Andishmand, Michael R Hamblin

Article2018

PAMAM dendrimers as efficient drug and gene delivery nanosystems for cancer therapy

Fereydoon Abedi Gaballu, Gholamreza Dehghan, Maryam Ghaffari, Reza Yekta, Soheil Abbaspour‐Ravasjani, Behzad Baradaran, Ali Ezzati, Michael R Hamblin